Denosumab increases spine bone density in women with anorexia nervosa: a randomized clinical trial.
Melanie Schorr HainesAllison KimballErinne MeenaghanKate SantosoCaitlin CollingVibha SinghalSeda EbrahimiSuzanne GleysteenMarcie SchneiderLori CiottiPerry BelferKamryn T EddyMadhusmita MisraKaren K MillerPublished in: European journal of endocrinology (2022)
Twelve months of antiresorptive therapy with denosumab reduced bone turnover and increased spine aBMD, the skeletal site most severely affected in women with anorexia nervosa.